Understanding mechanisms of virulence in MRSA: implications for antivirulence treatment strategies
Authors:
- 2 August 2023
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 21 (9) , 911-928
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is a widespread pathogen, often causing recurrent and deadly infections in the hospital and community. Many S. aureus virulence factors have been suggested as potential targets for antivirulence therapy to decrease the threat of diminishing antibiotic availability. Antivirulence methods hold promise due to their adjunctive and prophylactic potential and decreased risk for selective pressure. This review describes the dominant virulence mechanisms exerted by MRSA and antivirulence therapeutics that are currently undergoing testing in clinical or preclinical stages. We also discuss the advantages and downsides of several investigational antivirulence approaches, including the targeting of bacterial transporters, host-directed therapy, and quorum-sensing inhibitors. For this review, a systematic search of literature on PubMed, Google Scholar, and Web of Science for relevant search terms was performed in April and May 2023. Vaccine and antibody strategies have failed in clinical trials and could benefit from more basic science-informed approaches. Antivirulence-targeting approaches need to be set up better to meet the requirements of drug development, rather than only providing limited results to provide 'proof-of-principle' translational value of pathogenesis research. Nevertheless, there is great potential of such strategies and potential particular promise for novel probiotic approaches.Keywords
Funding Information
- the Intramural Program of the National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health (ZIA AI000904)
This publication has 256 references indexed in Scilit:
- Staphylococcus aureus α-Toxin: Nearly a Century of IntrigueToxins, 2013
- Extracellular proteases are key mediators of Staphylococcus aureus virulence via the global modulation of virulence‐determinant stabilityMicrobiologyopen, 2012
- Staphylococcus aureus Staphopain A inhibits CXCR2‐dependent neutrophil activation and chemotaxisThe EMBO Journal, 2012
- A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in miceNature Medicine, 2011
- Human Formyl Peptide Receptor 2 Senses Highly Pathogenic Staphylococcus aureusCell Host & Microbe, 2010
- Community-associated meticillin-resistant Staphylococcus aureusThe Lancet, 2010
- Waves of resistance: Staphylococcus aureus in the antibiotic eraNature Reviews Microbiology, 2009
- Host Defense and Pathogenesis in Staphylococcus aureus InfectionsInfectious Disease Clinics of North America, 2009
- RNAIII-Independent Target Gene Control by the agr Quorum-Sensing System: Insight into the Evolution of Virulence Regulation in Staphylococcus aureusMolecular Cell, 2008
- Iron Acquisition and Transport in Staphylococcus aureusBioMetals, 2006